We are live on ! Find out more
7IH

72 Investment Holdings Portfolio holdings

AUM $49.6M
1-Year Est. Return 684.72%
This Fund
S&P 500
This Quarter Est. Return
-14.11%
1 Year Est. Return
+684.72%
3 Year Est. Return
+1,518.31%
5 Year Est. Return
+6,127.68%
10 Year Est. Return
AUM
$91.4M
AUM Growth
-$21.3M
Cap. Flow
-$11
Cap. Flow %
-0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TRDA icon
Entrada Therapeutics
TRDA
+$11

Sector Composition

Rank Sector Weight
1 Healthcare 99.78%
2 Real Estate 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$69.8M 76.33%
1,848,024
PRAX icon
2
Praxis Precision Medicines
PRAX
$8.58B
$10.1M 11.05%
65,933
TRDA icon
3
Entrada Therapeutics
TRDA
$264M
$4.78M 5.23%
509,023
-1
-0% -$11
CRBU icon
4
Caribou Biosciences
CRBU
$145M
$4.35M 4.76%
474,067
OMGA
5
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$2.2M 2.41%
352,941
WE
6
DELISTED
WeWork Inc.
WE
$204K 0.22%
749

Similar funds

72 Investment Holdings's Q1 2022 Portfolio in Review

As of Q1 2022, 72 Investment Holdings held 6 positions worth $91.4M, down 19% from $113M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. 72 Investment Holdings opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Real Estate.

  • 72 Investment Holdings's biggest Q1 2022 reduction was Entrada Therapeutics, cutting an estimated $11.
  • 72 Investment Holdings's ten largest holdings make up 100% of its $91.4M portfolio in Q1 2022.
  • 72 Investment Holdings opened 0 new positions and closed 0 in Q1 2022.
  • 72 Investment Holdings's portfolio value fell 19% quarter-over-quarter to $91.4M.

Based on 72 Investment Holdings's 13F filing for Q1 2022, filed 16 May 2022.